Selective inhibition of tumor cell associated Vacuolar-ATPase ‘a2’ isoform overcomes cisplatin resistance in ovarian cancer cells-Reference-Cited by-同舟云学术

Selective inhibition of tumor cell associated Vacuolar-ATPase ‘a2’ isoform overcomes cisplatin resistance in ovarian cancer cells

Published:2016-01-29 Issue:6 Volume:10 Page:789-805
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Kulshrestha Arpita,Katara Gajendra K.,Ginter Jordyn,Pamarthy Sahithi,Ibrahim Safaa A.,Jaiswal Mukesh K.,Sandulescu Corina,Periakaruppan Ramayee,Dolan James,Gilman-Sachs Alice,Beaman Kenneth D.

Funder

ALGH-RFUMS

Advocate Lutheran General Hospital

Clinical Immunology Laboratory

Rosalind Franklin University of Medicine and Science

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.molonc.2016.01.003/fullpdf

Reference58 articles.

1. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth;Altomare;Oncogene,2004

2. Dysregulated pH in tumor microenvironment checkmates cancer therapy;Barar;Bioimpacts,2013

3. Cellular responses to cisplatin-induced DNA damage;Basu;J. Nucleic Acids,2010

4. The V-type H+ ATPase: molecular structure and function, physiological roles and regulation;Beyenbach;J. Exp. Biol,2006

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A nanobody against the V-ATPase c subunit inhibits metastasis of 4T1-12B breast tumor cells to lung in mice;Oncotarget;2024-08-14

2. ATP6V0A1-dependent cholesterol absorption in colorectal cancer cells triggers immunosuppressive signaling to inactivate memory CD8+ T cells;Nature Communications;2024-07-06

3. ATP6V0D1 promotes alkaliptosis by blocking STAT3-mediated lysosomal pH homeostasis;Cell Reports;2023-01

4. The V-ATPases in cancer and cell death;Cancer Gene Therapy;2022-05-03

5. PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer;Cell Death & Disease;2022-01-10